A new study has identified a genetic link between the use of GLP-1 weight loss medications, such as Ozempic, and an increased risk of hair loss in men.
Researchers found that individuals with specific genetic markers are more susceptible to this side effect, which is often reversible upon discontinuation of the drug.
Doctors are now being advised to screen patients for these genetic predispositions before prescribing weight loss treatments to mitigate potential cosmetic concerns.